Conference item icon

Conference item

4DCT oesophageal tumour delineation in SCOPE2 – how is radiotherapy quality assurance beneficial?

Abstract:
4DCT scanning in radiotherapy (RT) planning for distal oesophageal cancer enables the generation of patient specific target volumes by accounting for tumour motion. UK experience of this technique is increasing, facilitated by robust RT trial quality assurance (RTTQA) programmmes. We present outcomes to date of 4DCT RTTQA within the Study of Chemoradiotherapy in Oesophageal cancer including PET response and dose Escalation (SCOPE2), a currently recruiting phase II/III trial.
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1016/S0167-8140(18)31390-2

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Subgroup:
CRUK/MRC Ox Inst Radiation Oncology
Role:
Author
ORCID:
0000-0002-6669-0628
Expand authors...
Publisher:
Elsevier Publisher's website
Volume:
127
Pages:
S608
Publication date:
2018-06-18
Acceptance date:
2018-02-09
DOI:
EISSN:
1879-0887
ISSN:
0167-8140
Pubs id:
pubs:905644
URN:
uri:18efbbb1-f4af-4426-9117-c898333a8923
UUID:
uuid:18efbbb1-f4af-4426-9117-c898333a8923
Local pid:
pubs:905644

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP